ERBB2 and breast neoplasm: Our evidence that MDA-MB-453 cells cultured on collagen IV were more sensitive to the antiproliferative effect of JWG-045 might suggest that inhibition of ERK5 in combination therapy could constitute a particularly important strategy for counteracting HER2+ breast tumor resistance acquired through elevated expression of ECM and cell adhesion genes.